F-4/A EX-FILING FEES 0002032241 333-284430 N/A N/A 0002032241 1 2025-09-11 2025-09-11 0002032241 2 2025-09-11 2025-09-11 0002032241 3 2025-09-11 2025-09-11 0002032241 4 2025-09-11 2025-09-11 0002032241 5 2025-09-11 2025-09-11 0002032241 6 2025-09-11 2025-09-11 0002032241 2025-09-11 2025-09-11 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

F-4

United Hydrogen Global Inc.

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule		   Amount Registered   Proposed Maximum Offering
Price Per Unit		   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees Previously Paid   Equity   Class A Ordinary Shares, par value $0.0001 per share   (1)   Other   3,995,733   $ 11.26   $ 44,991,953.58   0.0001531   $ 6,888.27
Fees Previously Paid   Equity   Class A Ordinary Shares, par value $0.0001 per share   (2)   Other   1,446,400     11.26     16,286,464.00   0.0001531     2,493.46
Fees Previously Paid   Equity   Class A Ordinary Shares, par value $0.0001 per share   (3)   Other   150,000,000           7,391,535.00   0.0001531     1,131.64
Fees Previously Paid   Equity   Class A Ordinary Shares, par value $0.0001 per share   (4)   Other   1,725,000     11.26     19,423,500.00   0.0001531     2,973.74
Fees Previously Paid   Equity   Class A Ordinary Shares, par value $0.0001 per share   (5)   Other   332,000     11.26     3,738,320.00   0.0001531     572.34
Fees Previously Paid   Equity   Class A Ordinary Shares, par value $0.0001 per share   (6)   Other   69,000   $ 11.26   $ 776,940.00   0.0001531   $ 118.95
                                           
Total Offering Amounts:   $ 92,608,712.58         14,178.40
Total Fees Previously Paid:               18,184.39
Total Fee Offsets:               0.00
Net Fee Due:             $ 0.00

 

__________________________________________
Offering Note(s)

(1) All securities being registered will be issued by United Hydrogen Global Inc., an exempted company with limited liability incorporated in the Cayman Islands (“Pubco”). In connection with the business combination described in this registration statement and the enclosed prospectus (the “Business Combination”), among other things: (a) United Hydrogen Victor Limited, an exempted company with limited liability incorporated in the Cayman Islands and a wholly owned subsidiary of Pubco (the “First Merger Sub”), will merge with and into United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands (“United Hydrogen”), with United Hydrogen surviving such merger as a direct wholly owned subsidiary of Pubco (the “First Merger”); (b) in the context of the First Merger, all ordinary shares of United Hydrogen (except for the United Hydrogen Specially Designated Ordinary Shares, as defined in the proxy statement/prospectus) outstanding immediately prior to the First Merger will be cancelled and converted into newly issued Class A ordinary shares of Pubco (the “Pubco Class A Ordinary Shares”); (c) United Hydrogen Worldwide Limited, an exempted company with limited liability incorporated in the Cayman Islands and a wholly owned subsidiary of Pubco (the “Second Merger Sub”), will merge with and into Aimei Health Technology Co., Ltd, an exempted company incorporated in the Cayman Islands (“Aimei Health”), with Aimei Health surviving such merger as a direct wholly owned subsidiary of Pubco (the “Second Merger”); (d) in the context of the Second Merger, each outstanding ordinary share of Aimei Health (the “Aimei Health Ordinary Shares”) immediately prior to the Second Merger shall be cancelled and converted into one Pubco Class A Ordinary Share; and (f) each outstanding right of Aimei Health (the “Aimei Health Right”) will be canceled and converted into one-fifth (1/5) of one Pubco Class A Ordinary Share

Represents 3,995,733 Pubco Class A Ordinary Shares to be issued to holders of Aimei Health’s public shares, assuming no redemptions of Aimei Health public shares at Closing.

Estimated pursuant to Rule 457(c) solely for the purpose of computing the amount of the registration fee and based on the average of the high and low prices of the Aimei Health Ordinary Shares on the Nasdaq Global Market as of September 1012, 2025, within five business days prior to the date of filing of this registration statement.
(2) All securities being registered will be issued by United Hydrogen Global Inc., an exempted company with limited liability incorporated in the Cayman Islands (“Pubco”). In connection with the business combination described in this registration statement and the enclosed prospectus (the “Business Combination”), among other things: (a) United Hydrogen Victor Limited, an exempted company with limited liability incorporated in the Cayman Islands and a wholly owned subsidiary of Pubco (the “First Merger Sub”), will merge with and into United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands (“United Hydrogen”), with United Hydrogen surviving such merger as a direct wholly owned subsidiary of Pubco (the “First Merger”); (b) in the context of the First Merger, all ordinary shares of United Hydrogen (except for the United Hydrogen Specially Designated Ordinary Shares, as defined in the proxy statement/prospectus) outstanding immediately prior to the First Merger will be cancelled and converted into newly issued Class A ordinary shares of Pubco (the “Pubco Class A Ordinary Shares”); (c) United Hydrogen Worldwide Limited, an exempted company with limited liability incorporated in the Cayman Islands and a wholly owned subsidiary of Pubco (the “Second Merger Sub”), will merge with and into Aimei Health Technology Co., Ltd, an exempted company incorporated in the Cayman Islands (“Aimei Health”), with Aimei Health surviving such merger as a direct wholly owned subsidiary of Pubco (the “Second Merger”); (d) in the context of the Second Merger, each outstanding ordinary share of Aimei Health (the “Aimei Health Ordinary Shares”) immediately prior to the Second Merger shall be cancelled and converted into one Pubco Class A Ordinary Share; and (f) each outstanding right of Aimei Health (the “Aimei Health Right”) will be canceled and converted into one-fifth (1/5) of one Pubco Class A Ordinary Share

Represents (1) 1,380,000 Pubco Class A Ordinary Shares to the Aimei Health public shareholders in conversion of Public Rights; and (2) 66,400 Pubco Class A Ordinary Shares to the Aimei Health private shareholders in conversion of Private Rights.

Estimated pursuant to Rule 457(c) solely for the purpose of computing the amount of the registration fee and based on the average of the high and low prices of the Aimei Health Ordinary Shares on the Nasdaq Global Market as of September 1012, 2025, within five business days prior to the date of filing of this registration statement.
(3) All securities being registered will be issued by United Hydrogen Global Inc., an exempted company with limited liability incorporated in the Cayman Islands (“Pubco”). In connection with the business combination described in this registration statement and the enclosed prospectus (the “Business Combination”), among other things: (a) United Hydrogen Victor Limited, an exempted company with limited liability incorporated in the Cayman Islands and a wholly owned subsidiary of Pubco (the “First Merger Sub”), will merge with and into United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands (“United Hydrogen”), with United Hydrogen surviving such merger as a direct wholly owned subsidiary of Pubco (the “First Merger”); (b) in the context of the First Merger, all ordinary shares of United Hydrogen (except for the United Hydrogen Specially Designated Ordinary Shares, as defined in the proxy statement/prospectus) outstanding immediately prior to the First Merger will be cancelled and converted into newly issued Class A ordinary shares of Pubco (the “Pubco Class A Ordinary Shares”); (c) United Hydrogen Worldwide Limited, an exempted company with limited liability incorporated in the Cayman Islands and a wholly owned subsidiary of Pubco (the “Second Merger Sub”), will merge with and into Aimei Health Technology Co., Ltd, an exempted company incorporated in the Cayman Islands (“Aimei Health”), with Aimei Health surviving such merger as a direct wholly owned subsidiary of Pubco (the “Second Merger”); (d) in the context of the Second Merger, each outstanding ordinary share of Aimei Health (the “Aimei Health Ordinary Shares”) immediately prior to the Second Merger shall be cancelled and converted into one Pubco Class A Ordinary Share; and (f) each outstanding right of Aimei Health (the “Aimei Health Right”) will be canceled and converted into one-fifth (1/5) of one Pubco Class A Ordinary Share

Represents 150,000,000 Pubco Class A Ordinary Shares to be issued as merger consideration upon the Closing to certain Aimei Health shareholders pursuant to the Business Combination Agreement.

In accordance with Rule 457(f)(2) and Rule 457(c), as applicable, based on $7,391,535.00, the aggregate book value of United Hydrogen computed as of the latest practicable date prior to the date of filing the registration statement.
(4) All securities being registered will be issued by United Hydrogen Global Inc., an exempted company with limited liability incorporated in the Cayman Islands (“Pubco”). In connection with the business combination described in this registration statement and the enclosed prospectus (the “Business Combination”), among other things: (a) United Hydrogen Victor Limited, an exempted company with limited liability incorporated in the Cayman Islands and a wholly owned subsidiary of Pubco (the “First Merger Sub”), will merge with and into United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands (“United Hydrogen”), with United Hydrogen surviving such merger as a direct wholly owned subsidiary of Pubco (the “First Merger”); (b) in the context of the First Merger, all ordinary shares of United Hydrogen (except for the United Hydrogen Specially Designated Ordinary Shares, as defined in the proxy statement/prospectus) outstanding immediately prior to the First Merger will be cancelled and converted into newly issued Class A ordinary shares of Pubco (the “Pubco Class A Ordinary Shares”); (c) United Hydrogen Worldwide Limited, an exempted company with limited liability incorporated in the Cayman Islands and a wholly owned subsidiary of Pubco (the “Second Merger Sub”), will merge with and into Aimei Health Technology Co., Ltd, an exempted company incorporated in the Cayman Islands (“Aimei Health”), with Aimei Health surviving such merger as a direct wholly owned subsidiary of Pubco (the “Second Merger”); (d) in the context of the Second Merger, each outstanding ordinary share of Aimei Health (the “Aimei Health Ordinary Shares”) immediately prior to the Second Merger shall be cancelled and converted into one Pubco Class A Ordinary Share; and (f) each outstanding right of Aimei Health (the “Aimei Health Right”) will be canceled and converted into one-fifth (1/5) of one Pubco Class A Ordinary Share

Estimated pursuant to Rule 457(c) solely for the purpose of computing the amount of the registration fee and based on the average of the high and low prices of the Aimei Health Ordinary Shares on the Nasdaq Global Market as of September 1012, 2025, within five business days prior to the date of filing of this registration statement.
(5) All securities being registered will be issued by United Hydrogen Global Inc., an exempted company with limited liability incorporated in the Cayman Islands (“Pubco”). In connection with the business combination described in this registration statement and the enclosed prospectus (the “Business Combination”), among other things: (a) United Hydrogen Victor Limited, an exempted company with limited liability incorporated in the Cayman Islands and a wholly owned subsidiary of Pubco (the “First Merger Sub”), will merge with and into United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands (“United Hydrogen”), with United Hydrogen surviving such merger as a direct wholly owned subsidiary of Pubco (the “First Merger”); (b) in the context of the First Merger, all ordinary shares of United Hydrogen (except for the United Hydrogen Specially Designated Ordinary Shares, as defined in the proxy statement/prospectus) outstanding immediately prior to the First Merger will be cancelled and converted into newly issued Class A ordinary shares of Pubco (the “Pubco Class A Ordinary Shares”); (c) United Hydrogen Worldwide Limited, an exempted company with limited liability incorporated in the Cayman Islands and a wholly owned subsidiary of Pubco (the “Second Merger Sub”), will merge with and into Aimei Health Technology Co., Ltd, an exempted company incorporated in the Cayman Islands (“Aimei Health”), with Aimei Health surviving such merger as a direct wholly owned subsidiary of Pubco (the “Second Merger”); (d) in the context of the Second Merger, each outstanding ordinary share of Aimei Health (the “Aimei Health Ordinary Shares”) immediately prior to the Second Merger shall be cancelled and converted into one Pubco Class A Ordinary Share; and (f) each outstanding right of Aimei Health (the “Aimei Health Right”) will be canceled and converted into one-fifth (1/5) of one Pubco Class A Ordinary Share

Estimated pursuant to Rule 457(c) solely for the purpose of computing the amount of the registration fee and based on the average of the high and low prices of the Aimei Health Ordinary Shares on the Nasdaq Global Market as of September 10, 2025, within five business days prior to the date of filing of this registration statement.
(6) All securities being registered will be issued by United Hydrogen Global Inc., an exempted company with limited liability incorporated in the Cayman Islands (“Pubco”). In connection with the business combination described in this registration statement and the enclosed prospectus (the “Business Combination”), among other things: (a) United Hydrogen Victor Limited, an exempted company with limited liability incorporated in the Cayman Islands and a wholly owned subsidiary of Pubco (the “First Merger Sub”), will merge with and into United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands (“United Hydrogen”), with United Hydrogen surviving such merger as a direct wholly owned subsidiary of Pubco (the “First Merger”); (b) in the context of the First Merger, all ordinary shares of United Hydrogen (except for the United Hydrogen Specially Designated Ordinary Shares, as defined in the proxy statement/prospectus) outstanding immediately prior to the First Merger will be cancelled and converted into newly issued Class A ordinary shares of Pubco (the “Pubco Class A Ordinary Shares”); (c) United Hydrogen Worldwide Limited, an exempted company with limited liability incorporated in the Cayman Islands and a wholly owned subsidiary of Pubco (the “Second Merger Sub”), will merge with and into Aimei Health Technology Co., Ltd, an exempted company incorporated in the Cayman Islands (“Aimei Health”), with Aimei Health surviving such merger as a direct wholly owned subsidiary of Pubco (the “Second Merger”); (d) in the context of the Second Merger, each outstanding ordinary share of Aimei Health (the “Aimei Health Ordinary Shares”) immediately prior to the Second Merger shall be cancelled and converted into one Pubco Class A Ordinary Share; and (f) each outstanding right of Aimei Health (the “Aimei Health Right”) will be canceled and converted into one-fifth (1/5) of one Pubco Class A Ordinary Share

Estimated pursuant to Rule 457(c) solely for the purpose of computing the amount of the registration fee and based on the average of the high and low prices of the Aimei Health Ordinary Shares on the Nasdaq Global Market as of September 1012, 2025, within five business days prior to the date of filing of this registration statement.